We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Electronic Medical Records Speed Genetic Research

By LabMedica International staff writers
Posted on 10 May 2011
Print article
A new study revealed that mining data from electronic medical records (EMRs) is a faster way to get insights into disease processes.

Recruiting thousands of patients to collect health data for genetic clues to disease is expensive and time consuming. However, process of collecting data for genetic studies could be faster and cheaper by instead mining patient data that already exists in electronic medical records, according to new research.

In the study, researchers were able to cull patient information in EMRs from routine physicians' visits at five US sites that all used different brands of medical record software. The information allowed researchers to identify accurately patients with five kinds of diseases or health disorders--type 2 diabetes, dementia, peripheral arterial disease, cataracts, and cardiac conduction.

"The hard part of doing genetic studies has been identifying enough people to get meaningful results," said lead investigator Abel Kho, MD, an assistant professor of medicine at Northwestern University Feinberg School of Medicine (Chicago, IL, USA) and a physician at Northwestern Memorial Hospital. "Now we've shown you can do it using data that's already been collected in electronic medical records and can rapidly generate large groups of patients."

The study's findings were published April 20, 2011, in the journal Science Translational Medicine. To identify the diseases, Dr. Kho and colleagues searched the records using a series of criteria such as medications, diagnoses, and laboratory tests. They then tested their results against the gold standard-- review by physicians. The physicians validated the results, according to Dr. Kho. The electronic health records allowed researchers to identify patients' diseases with 73% to 98% accuracy.

The researchers also were able to reproduce previous genetic findings from prospective studies using the EMRs. The five institutions that participated in the study collected genetic samples for research. Patients agreed to the use of their records for studies.

Sequencing individuals' genomes is becoming faster and less expensive. It soon may be possible to include patients' genomes in their medical records, Dr. Kho noted. This would create a plentiful resource for genetic research. "With permission from patients, you could search electronic health records at not just five sites but 25 or 100 different sites and identify 10,000 or 100,000 patients with diabetes, for example," Dr. Kho said.

The larger the group of patients for genetic studies, the better the ability to detect rarer affects of the genes and the more detailed genetic sequences that cause a person to develop a disease. The study also revealed across-the-board weaknesses in institutions' electronic medical records. The institutions didn't do a good job of capturing race and ethnicity, smoking status, and family history, all which are important areas of study, Dr. Kho reported. "It shows we need to focus our efforts to use electronic medical records more meaningfully," he added.

The institutions participating in the study are part of a consortium called the Electronic Medical Records and Genomics Network (eMERGE). The research was supported by the US National Human Genome Research Institute with additional funding from the US National Institute of General Medical Sciences, both based in Bethesda, MD, USA.

Related Links:

Northwestern University Feinberg School of Medicine


Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Cortisol Rapid Test
Finecare Cortisol Rapid Quantitative Test
New
Silver Member
Rubella Infection ELISA
ReQuest RUBELLA IgM ELISA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.